机构风向标 | 信邦制药(002390)2025年三季度已披露持仓机构仅8家

Group 1 - The core viewpoint of the news is that Xinfang Pharmaceutical (002390.SZ) reported a decrease in institutional ownership in its third-quarter report for 2025, with a total of 8 institutional investors holding 771 million shares, representing 39.65% of the total share capital, a decline of 0.89 percentage points from the previous quarter [1] Group 2 - In the public fund sector, there was a slight increase in holdings from one fund, the Agricultural Bank of China CSI 1000 Index Enhanced A, while one fund, the Southern CSI 1000 ETF, saw a slight decrease in holdings compared to the previous quarter [2] - Two new public funds were disclosed this period, including Dachen Fengxiang Return Mixed A and Dachen Absolute Return Mixed Initiation A, while 75 public funds were not disclosed this quarter, including major funds like Huaxia CSI 1000 ETF and GF CSI 1000 ETF [2] - Regarding foreign investment, one foreign fund, Hong Kong Central Clearing Limited, reduced its holdings slightly compared to the previous quarter [2]